BROWN MICHAEL S sold REGN
June 14, 2024 · Form 4 insider transaction
BROWN MICHAEL S sold 1,535 shares of Regeneron Pharmaceuticals, Inc. at $1040.00 per share, a transaction worth $1.60M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,535
Price
$1040.00
Total value
$1.60M
InsiderBROWN MICHAEL S
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 14, 2024
Filing dateJune 17, 2024
Shares owned after1,382
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 26, 2024.